- Home
- / Kernal Biologics
Kernal Biologics
Total Funding
$25.5 M
Kernal Biologics Summary
Company Summary
- Overview
- Kernal Biologics is a biotech company creating mRNA therapies that instruct specific cells on how to make their own drugs. It specializes in applying its mRNA technology to develop vaccines against COVID-19 and oncolytic virus-based immuno-oncology drugs, among other things.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://www.kernalbio.com/
- Cybersecurity rating
Table of Contents
Key People
Burak Yilmaz, President & Co-Founder
Manfred Kraus, Vice President, Head of R&D Therapeutics
Cafer Ozdemir, Director of Convergence Science & Co-Founder
LocationsView all
1 location detected
Cambridge, MA HQ
United States
700 Main St